Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Als symbols : Tnxp save search
Tonix Pharmaceuticals Announces Phase 3 RALLY Study Results for TNX-102 SL 5.6 mg for the Management of Fibromyalgia
Published: 2022-03-21 (Crawled : 13:00) - biospace.com/
TNXP | $0.1549 -2.82% -2.91% 1.4M
|
Health Technology
|
| O: -6.79%
H: 18.46%
C: 8.4%
tnx-102 als fibromyalgia phase 3
Tonix Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial Results and Operational Highlights
Published: 2022-03-14 (Crawled : 14:30) - biospace.com/
TNXP | $0.1549 -2.82% -2.91% 1.4M
|
Health Technology
|
| O: 3.05%
H: 0.0%
C: -8.62%
als financial results report results tiona
Tonix Pharmaceuticals Announces Appointment of Jeffrey Rosenfeld, Ph.D., as Executive Director, Genomics and Bioinformatics
Published: 2022-03-09 (Crawled : 23:00) - globenewswire.com
TNXP | $0.1549 -2.82% -2.91% 1.4M
|
Health Technology
|
| O: 5.32%
H: 1.01%
C: -2.86%
als genomics ces genomic
Tonix Pharmaceuticals Announces Collaboration with Massachusetts General Hospital to Evaluate TNX-1900 (Intranasal Potentiated Oxytocin) for Treating Binge Eating Disorder
Published: 2022-03-07 (Crawled : 18:00) - biospace.com/
TNXP | $0.1549 -2.82% -2.91% 1.4M
|
Health Technology
|
| O: 5.17%
H: 1.06%
C: -8.08%
tnx-1900 als order announces collaboration collaboration set oxytocin potential
Tonix Pharmaceuticals Announces FDA Orphan-Drug Designation for TNX-2900 for the Treatment of Prader-Willi Syndrome
Published: 2022-03-03 (Crawled : 20:00) - biospace.com/
TNXP | $0.1549 -2.82% -2.91% 1.4M
|
Health Technology
|
| O: 46.52%
H: 28.57%
C: -9.18%
tnx-2900 treatment fda als drug drug designation syndros designation
Tonix Pharmaceuticals Announces Research Agreement with the French National Institute of Health and Medical Research (Inserm) to Study the Mechanism of Oxytocin-Mediated Improvement of Eating Behaviors in Prader-Willi Mice
Published: 2022-02-28 (Crawled : 15:00) - biospace.com/
TNXP | $0.1549 -2.82% -2.91% 1.4M
|
Health Technology
|
| O: 1.2%
H: 6.32%
C: 4.4%
health als research media oxytocin ism
Tonix Pharmaceuticals to Participate in BIO CEO & Investor Conference
Published: 2022-02-07 (Crawled : 13:30) - globenewswire.com
TNXP | $0.1549 -2.82% -2.91% 1.4M
|
Health Technology
|
| O: 4.03%
H: 5.07%
C: 2.51%
als ceo conference
Tonix Pharmaceuticals to Participate in Upcoming January 2022 Conferences
Published: 2022-01-05 (Crawled : 10:00) - biospace.com/
TNXP | $0.1549 -2.82% -2.91% 1.4M
|
Health Technology
|
| O: -9.03%
H: 0.0%
C: 0.0%
als ces conference
Tonix Pharmaceuticals to Participate in Upcoming January Conferences
Published: 2022-01-05 (Crawled : 12:30) - globenewswire.com
TNXP | $0.1549 -2.82% -2.91% 1.4M
|
Health Technology
|
| O: -9.03%
H: 0.0%
C: 0.0%
als conference
Tonix Pharmaceuticals Announces Exclusive Option and Research Collaboration with Kansas State University to Develop LNP-Free mRNA Vaccines
Published: 2022-01-04 (Crawled : 23:00) - biospace.com/
TNXP | $0.1549 -2.82% -2.91% 1.4M
|
Health Technology
|
| O: 3.81%
H: 0.0%
C: 0.0%
als research collaboration vaccine
Tonix Pharmaceuticals Added to the Nasdaq Biotechnology Index
Published: 2021-12-15 (Crawled : 12:30) - globenewswire.com
TNXP | $0.1549 -2.82% -2.91% 1.4M
|
Health Technology
|
| O: 3.28%
H: 5.19%
C: 4.66%
als technology index biotech iot nasdaq
Tonix Pharmaceuticals Announces IND Clearance for Skin Test (TNX-2100) to Measure SARS-CoV-2 Exposure and T Cell Immunity
Published: 2021-12-14 (Crawled : 12:30) - globenewswire.com
SNYNF | News | $92.7 -2.18% 1.4K
|
Health Technology
|
| O: -3.62%
H: 0.0%
C: -0.56%
TNXP | $0.1549 -2.82% -2.91% 1.4M
|
Health Technology
|
| O: 5.33%
H: 0.0%
C: 0.0%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: -0.51%
H: 0.0%
C: 0.0%
tnx-2100 als clearance skin cel sars-cov-2 test t-cell
Tonix Pharmaceuticals Announces Research Collaboration with Columbia University to Study Recombinant Trefoil Factor 2 (rTFF2)-Based Therapy (TNX-1700) for Gastric and Colorectal Cancers
Published: 2021-12-13 (Crawled : 21:00) - globenewswire.com
TNXP | $0.1549 -2.82% -2.91% 1.4M
|
Health Technology
|
| O: 0.44%
H: 0.0%
C: 0.0%
tnx-1700 als research therapy collaboration cancer colorectal cancer
Gainers vs Losers
| 64% | 36% |
Top 10 Gainers
AGBA | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $2.86 108.76% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | $0.92 84.0% 45.65% 1.6M
|
OST | $0.499 21.38% 45.26% 1.9M
|
XPON | $3.1 60.62% 37.74% 17M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Your saved searches
Save your searches and get alerts when important news are released.